Cargando…
Genomic analysis of biomarkers related to the prognosis of acute myeloid leukemia
Acute myeloid leukemia (AML) is the most common childhood cancer and is a major cause of morbidity among adults with hematologic malignancies. Several novel genetic alterations, which target critical cellular pathways, including alterations in lymphoid development-regulating genes, tumor suppressors...
Autores principales: | Li, Guilan, Gao, Yang, Li, Kun, Lin, Anqi, Jiang, Zujun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7377096/ https://www.ncbi.nlm.nih.gov/pubmed/32724426 http://dx.doi.org/10.3892/ol.2020.11700 |
Ejemplares similares
-
Identification of the Thyrotropin-Releasing Hormone (TRH) as a Novel Biomarker in the Prognosis for Acute Myeloid Leukemia
por: Gao, Yan, et al.
Publicado: (2022) -
Comprehensive Genomic Analysis for Identifying FZD6 as a Novel Diagnostic Biomarker for Acute Myeloid Leukemia
por: Yang, Li, et al.
Publicado: (2022) -
The prognosis biomarkers based on m6A-related lncRNAs for myeloid leukemia patients
por: Yang, Li-Rong, et al.
Publicado: (2022) -
Comprehensive analysis of PTPN family expression and prognosis in acute myeloid leukemia
por: Liu, Yong, et al.
Publicado: (2023) -
Identification of A‐kinase interacting protein 1 as a potential biomarker for risk and prognosis of acute myeloid leukemia
por: Yan, Yan, et al.
Publicado: (2020)